COVID-19 trials registries data warehouse

 Return to trial list

Trial - EUCTR2020-001549-38-DE


Column Value
Trial registration number EUCTR2020-001549-38-DE
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

First author
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Gesundheit Nord gGmbH - Institut für Pharmakologie

Contact
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

i.puentmann@pharmakologie-bremen.de

Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

2020-04-06

Recruitment status
Last imported at : June 17, 2021, 1:30 a.m.
Source : EU Clinical Trials Register

Terminated

Study design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

RCT

Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Randomized

Design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Parallel

Masking
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Open label

Center
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

multi-center

Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Treatment

Inclusion criteria
Last imported at : Nov. 10, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

Patients 18 years and older SARS-CoV-2 infection confirmed by PCR in any specimen < 9 days prior to randomization Admitted to the hospital ward or the ICU due to COVID-19 SpO2 ≤ 94% on room air OR oxygen demand OR breathing support Written informed consent obtained

Exclusion criteria
Last imported at : Nov. 10, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

Patient's non-consent or inability to informed consent Pregnant or breastfeeding women Subjects pretreated with one of the active study drugs in the past 29 days Anticipated transfer within 72 hours to a non-study hospital Severe co-morbidity with life expectancy < 3 months according to investigators opinion AST or ALT > 5 times the upper limit of normal Stage 4 severe chronic kidney disease or requiring dialysis (i.e. eGFR < 30 mL/min) Contraindications to any of the active study drugs Subjects participating in a potentially confounding drug or device trial during the course of the study in the last 29 days Any reason why, in the opinion of the investigators, the patient should not participate

Number of arms
Last imported at : Nov. 10, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

2

Funding
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Gesundheit Nord gGmbH

Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

18

Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

100

Countries
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Germany

Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Severe disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

6: Severe disease at enrollment

Total sample size
Last imported at : Nov. 10, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

400

primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

improvement of the clinical status on the ordinal 7-point severity-scale at day 15: 1. Not hospitalized, no limitations on activities, 2. Not hospitalized, limitation on activities, 3. Hospitalized, not requiring supplemental oxygen, 4. Hospitalized, requiring supplemental oxygen, 5. Hospitalized, on non-invasive ventilation or high flow oxygen devices, 6. Hospitalized, on invasive mechanical ventilation or ECMO, 7. Death

Notes
Last imported at : Nov. 10, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

Declared number of arm (2.0) differs from found arms (1.0)

Phase
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Phase 3

Arms
Last imported at : Nov. 10, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

[{"arm_notes": "", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]